At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 36 enrolled

Drug / intervention

Clindamycin and BPO 5% gel +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01015638

NCT01015638Phase 4Completed

Compare CT.gov

Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac® Topical Gel (Clindamycin 1% and Benzoyl Peroxide 5%) to ACANYA™ Gel (Clindamycin Phosphate 1.2% and Benzoyl Peroxide 2.5%) Topical Acne Medications

Stiefel, a GSK Company·interventional·Posted Nov 18, 2009·Updated Mar 31, 2017

In Brief

A Phase 4 clinical trial evaluating Clindamycin and BPO 5% gel and Clindamycin phosphate and benzoyl peroxide 2.5% gel. for Acne Vulgaris. Completed, enrolled 36 participants across 1 site.

Detailed Summary

This is a single-blind (blinded expert grader) study that will enroll 25-30 healthy volunteers without facial acne. On 1 side of the face, the subject will apply 1 of the 2 test products, clindamycin and benzoyl peroxide 5% or clindamycin phosphate and benzoyl peroxide 2.5% and the other side of the face will remain non-treated to serve as a control.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAcne Vulgaris

CountriesUnited States

CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished

20102011201220132014201520162017201820192020202120222023202420252026

Enrollment StartAug 2009

Primary CompletionSep 2009

First PostedNov 2009

TodayJul 2026

First PostedNov 18, 2009

Enrollment StartAug 1, 2009

Primary CompletionSep 1, 2009

TodayJul 2, 2026

Enrollment to primary: 1 monthPosted 16.6 years ago

Interventions

Clindamycin and BPO 5% geldrug

Once-daily applications, to the randomized side of the face either left or right, of clindamycin and benzoyl peroxide (BPO) 5% gel.

Clindamycin phosphate and benzoyl peroxide 2.5% gel.drug

Once daily application of clindamycin phosphate and benzoyl peroxide (BPO) 2.5% gel